TransEnterix (TRXDW) vs. Its Peers Head-To-Head Review

Volatility and Risk

TransEnterix has a beta of 2.56, suggesting that its stock price is 156% more volatile than the S&P 500. Comparatively, TransEnterix’s rivals have a beta of 1.78, suggesting that their average stock price is 78% more volatile than the S&P 500.

Profitability

This table compares TransEnterix and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TransEnterix	-2,149.15%	-83.74%	-64.94%
TransEnterix Competitors	-570.12%	-123.56%	-53.83%

Institutional and Insider Ownership

8.2% of TransEnterix shares are held by institutional investors. Comparatively, 19.3% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 3.1% of TransEnterix shares are held by insiders. Comparatively, 19.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares TransEnterix and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TransEnterix	$8.53 million	-$154.20 million	-0.04
TransEnterix Competitors	$61.67 million	-$32.64 million	5.30

TransEnterix’s rivals have higher revenue and earnings than TransEnterix. TransEnterix is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

TransEnterix rivals beat TransEnterix on 7 of the 9 factors compared.

TransEnterix Company Profile

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.